Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are two antiretroviral
medications used for the treatment and prevention of HIV/AIDS. This study will examine how
these medications are processed in the body of people who are HIV-infected, as well as in
people who are HIV-uninfected.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir